Aadi Bioscience Conference: Whitehawk Unveils 3-Program ADC Pipeline, Targets First Data in 2027 [Yahoo! Finance]
Whitehawk Therapeutics, Inc. (WHWK)
Company Research
Source: Yahoo! Finance
million in cash at Q3 and says that funding should support operations into early 2028 , while targeting initial clinical readouts for its lead ADCs in the first half of 2027 (with the third program planned to start later). The company runs a three-program ADC platform built around a shared, deruxtecan-like topo-1 payload and licensed linker-payload system CPT-113 , using a DAR of 6 and claiming very high circulation stability (payload release ~ molar, or ~ 10x–100x more stable than typical ADCs) to boost tumor delivery and tolerability. Program highlights: HWK-007 (PTK7) is entering dose escalation and targets a widely expressed antigen (up to ~70% of tumors) with ~20–30 patients expected at readout; HWK-016 (MUC16) is engineered to bind below the CA-125 cleavage site to avoid an antigen sink and aims for high ORRs in gynecologic cancers; and HWK-206 (SEZ6) is a biparatopic ADC planned for IND/Phase 1 initiation in Q3. Interested in Aadi Bioscience, Inc.? Here are five stocks we
Show less
Read more
Impact Snapshot
Event Time:
WHWK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WHWK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WHWK alerts
High impacting Whitehawk Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
WHWK
News
- Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights [Yahoo! Finance]Yahoo! Finance
- Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent HighlightsPR Newswire
- Whitehawk Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Whitehawk Therapeutics to Participate in Upcoming Investor ConferencesPR Newswire
- Aadi Bioscience Conference: CEO Spotlights Whitehawk ADC Pipeline, Cash Runway Through 2028 [Yahoo! Finance]Yahoo! Finance